CDH13, cadherin 13, 1012

N. diseases: 205; N. variants: 47
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.060 AlteredExpression disease LHGDN T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells. 17573778 2007
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.060 PosttranslationalModification disease LHGDN Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma. 17094449 2006
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.060 AlteredExpression disease LHGDN T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells. 15816843 2005
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.060 AlteredExpression disease BEFREE Among the 10 selected genes, insulin-like growth factor-binding protein-3, inhibitor of apoptosis protein 1, and cadherin-13 were more frequently expressed in SCC cell lines. 15099960 2004
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.060 AlteredExpression disease LHGDN Although no structural genomic alternations were found by sequence analysis, aberrant promoter methylation of the T-cadherin gene was found in 12 of 28 invasive squamous cell carcinomas. 12177241 2002
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.060 PosttranslationalModification disease BEFREE Although no structural genomic alternations were found by sequence analysis, aberrant promoter methylation of the T-cadherin gene was found in 12 of 28 invasive squamous cell carcinomas. 12177241 2002
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.060 Biomarker disease BEFREE These results suggest that flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content of pretreatment tumor biopsies may be a potentially useful predictive assay in patients irradiated for advanced squamous cell carcinomas of the head and neck. 7913703 1994